PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.1206

Related search